Dianthus Therapeutics, Inc.
(NASDAQ: DNTH)
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
53.790 -
+3.290
(+6.51%)
Range
50.790 - 54.590
(7.48%)
Open
51.810
Previous Close
50.500
Bid Price
53.670
Bid Volume
90
Ask Price
54.050
Ask Volume
25
Volume
845,413
Value
31,888,559
Remark
-
Delayed prices. Updated at 30 Jan 2026 04:46.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
